Burdie65 schreef op 27 februari 2018 00:43:
HAEi Polen (Info op de HAEi site)
Current patients as per 2017, 300 to 320. There should be around 700-800 patients in total in Poland.
10 medical center, 30 physicians and 20 nurses.
Medications available:
C1 inhibitor is reimbursed with the validity of the reimbursement till March 2018 for Berinert 500 and November 2017 for Berinert 1500.
C1 recombinant inhibitor is reimbursed till March 2020 (Ruconest), and Icatibant (Firazyr) is reimbursed till June 2017. The validation of the reimbursement decisions can be extended by the pharmaceuticals after a renewed application and negotiation process with the Polish Ministry of Health.